Aptinyx Reports First Quarter 2019 Financial Results and Provides Corporate Update

    NEXT STORY
    Precision BioSciences Appoints Christopher R. Heery, M.D., as Chief Medical Officer
    PREV STORY
    Achillion Granted Twentieth Patent for Factor D Portfolio
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Global Therapeutic Vaccines Market Insights Report 2019-2023: Rising Incidence & Prevalence of Diseases and Strong Therapeutic Vaccine Pipeline Will Provide Significant Growth Opportunities

    author_avatar
    NASDAQ Market News

    Cesca Therapeutics Strengthens Leadership Team and Board of Directors

    Appoints Ms. Vivian Liu as Chief Operating Officer Elects Dr. Russell Medford to its ...

    author_avatar
    NASDAQ Market News

    OncoMed Announces Publication of Phase 1a Data of Navicixizumab

    Objective Responses Observed in Heavily-pretreated Ovarian Cancer Patients Treated with Navicixzumab MonotherapyREDWOOD CITY, Calif., ...

    author_avatar
    NASDAQ Market News